Time for state debate on stem-cell research
Tags: STEM cells -- Research; EMBRYONIC stem cells; MEDICINE, Preventive; GOVERNMENT policy; HUMAN reproductive technology
Related Articles
- Science policy and public accountability in Poland: the case of embryonic stem-cell research. Kulawik, Teresa // Science & Public Policy (SPP);Jul2009, Vol. 36 Issue 6, p468
This article examines how exercises of public involvement in science policy, which have been transported to the new member states via EU regulations, function in post-socialist democracies. Given Poland's agonistic and non-transparent policy style, the public consultation process in the case of...
- Stem Cells, Life and the Law. Keiper, Adam; Levin, Yuval // Human Life Review;Summer2010, Vol. 36 Issue 3, p110
A court battle over embryonic stem-cell research that relate to articles that appeared in the June 2010 issue of "The Human Life Review" is presented.
- An Overview on Stem Cell Research and Regulatory Issues. Cogle, Christopher R.; Guthrie, Steven M.; Sanders, Ronald C.; Allen, William L.; Scott, Edward W.; Petersen, Bryon E. // Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p993
Stem cells are noted for their ability to self-renew and differentiate into a variety of cell types. Some stem cells, described as totipotent cells, have tremendous capacity to self-renew and differentiate. Embryonic stem cells have pluripotent capacity, able to form tissues of all 3 germ layers...
- Prometheus, Pandora, and the Myths of Cloning. Van Gend, David // Human Life Review;Summer/Fall2006, Vol. 32 Issue 3/4, p15
The author discusses issues related to the implications of stem-cell research and cloning for the medical field in the U.S. According to the author, cloning is redundant because research on using embryonic stem cells to develop treatments has encountered problems where adult stem-cell research...
- Payment of egg donors in stem cell research in the USA. Klitzman, Robert; Sauer, Mark V. // Reproductive BioMedicine Online;May2009, Vol. 18 Issue 5, p603
Arguments have been put forth as to whether women who donate oocytes for human embryonic stem cell (HESC) research should be compensated, but data regarding this issue have been scant. Recently in the United States, several States have begun funding HESC research, and patient recruitment efforts...
- The EU will probably fund stem cell research. // Reproductive BioMedicine Online;Sep2006, Vol. 13 Issue 3, p320
The article focuses on the debate over the assisted human reproduction. The Roman Catholic Church leads the opposition to preparing human embryo stem (ES) cell lines from individual human embryos. This follows earlier votes in the United Nations and the decision by U.S. President George W. Bush...
- Is a consensus possible on stem cell research? Moral and political obstacles. Brock, D. W. // Journal of Medical Ethics;Jan2006, Vol. 32 Issue 1, p36
The article discusses moral and political obstacle in human embryonic stem cell research (HESC). The first obstacle to consensus is that HESC research typically requires the destruction of human embryos in order to develop stem cell lines on which research can be done. The second obstacle to...
- Surplus embryos in Switzerland in 2003: legislation and availability of human embryos for research. Puorger, U. P. S. Koeferl; Buergin, M.; Wunder, D.; Crazzolara, S.; Birkhaeuser, M. H. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Dec2006, Vol. 13 Issue 6, p772
Legislation influences the availability of embryos for research. The law in Switzerland, and in some other European countries, is restrictive concerning medically assisted reproduction and stem cell research. Swiss law prohibits the creation of embryos for research purposes. It permits the...
- CALIFORNIA SCHEMING. // New Scientist;12/10/2005, Vol. 188 Issue 2529, p7
The article reports that Californian voters may have authorised the spending of $3 billion of public money on stem cell research over the next decade, but opponents of the plan are determined to make it as hard as possible to spend the money. Activists who oppose research on human embryonic stem...
